which has more side effects semaglutide or tirzepatide Comparative safety and of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide vs Tirzepatide vs Retatrutide

Hormonal imbalances, insulin resistance, and metabolic changes all play a role in making weight loss with PCOS uniquely difficult

Improved diabetes management and prevention Our patients with type 2 diabetes or prediabetes achieve a 0.51.5% reduction in HbA1c supporting better blood sugar control and long-term metabolic health

When you come in for your consultation, well decide on your best option for treatment

If you're considering taking your injection one day early, it's natural to wonder whether a 24-hour shift will affect your results or safetyand the answer depends on several factors including your dosing pattern, body composition, and individual response to the medication

The compound received FDA GRAS status for safety but was never approved as a drug because efficacy was insufficient for pharmaceutical registration

News provided by Eli Lilly and Company May 21, 2026, 06:45 ET In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery Individuals with a baseline BMI 35 who participated in a study extension continued to lose weight, and achieved up to an average of 85.0 lbs (30.3%) weight loss at 104 weeks At the 4 mg dose, reached with only a single escalation step, participants lost an average of 47.2 lbs (19.0%) at 80 weeks with a lower observed discontinuation rate due to adverse events vs